title: Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response.
abstract: OBJECTIVE
  We investigated whether variation in MTNR1B, which was recently identified as a common genetic determinant of fasting glucose levels in healthy, diabetes-free individuals, is associated with measures of beta cell function and whole-body insulin sensitivity.
  
  
  METHODS
  We studied 1,276 healthy individuals of European ancestry at 19 centres of the Relationship between Insulin Sensitivity and Cardiovascular disease (RISC) study. Whole-body insulin sensitivity was assessed by euglycaemic-hyperinsulinaemic clamp and indices of beta cell function were derived from a 75 g oral glucose tolerance test (including 30 min insulin response and glucose sensitivity). We studied rs10830963 in MTNR1B using additive genetic models, adjusting for age, sex and recruitment centre.
  
  
  RESULTS
  The minor (G) allele of rs10830963 in MTNR1B (frequency 0.30 in HapMap Centre d'Etude du Polymorphisme [Utah residents with northern and western European ancestry] [CEU]; 0.29 in RISC participants) was associated with higher levels of fasting plasma glucose (standardised beta [95% CI] 0.17 [0.085, 0.25] per G allele, p = 5.8 x 10(-5)), consistent with recent observations. In addition, the G-allele was significantly associated with lower early insulin response (-0.19 [-0.28, -0.10], p = 1.7 x 10(-5)), as well as with decreased beta cell glucose sensitivity (-0.11 [-0.20, -0.027], p = 0.010). No associations were observed with clamp-assessed insulin sensitivity (p = 0.15) or different measures of body size (p > 0.7 for all).
  
  
  CONCLUSIONS
  Genetic variation in MTNR1B is associated with defective early insulin response and decreased beta cell glucose sensitivity, which may contribute to the higher glucose levels of non-diabetic individuals carrying the minor G allele of rs10830963 in MTNR1B.
authors.affiliation: MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK. claudia.langenberg@mrc-epid.cam.ac.uk
authors.forename: C
authors.initials: C
authors.lastname: Langenberg
authors.forename: L
authors.initials: L
authors.lastname: Pascoe
authors.forename: A
authors.initials: A
authors.lastname: Mari
authors.forename: A
authors.initials: A
authors.lastname: Tura
authors.forename: M
authors.initials: M
authors.lastname: Laakso
authors.forename: T M
authors.initials: TM
authors.lastname: Frayling
authors.forename: I
authors.initials: I
authors.lastname: Barroso
authors.forename: R J F
authors.initials: RJ
authors.lastname: Loos
authors.forename: N J
authors.initials: NJ
authors.lastname: Wareham
authors.forename: M
authors.initials: M
authors.lastname: Walker
mesh_terms: D000328:Adult; D005260:Female; D014644:Genetic Variation; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000494:pharmacology / Q000502:physiology*; D007333:Insulin Resistance / Q000235:genetics; D050417:Insulin-Secreting Cells / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D008957:Models, Genetic; D044122:Receptor, Melatonin, MT1 / Q000235:genetics*; D044123:Receptor, Melatonin, MT2 / Q000235:genetics; D044465:White People / Q000235:genetics
chemical_list: D007328:Insulin; D044122:Receptor, Melatonin, MT1; D044123:Receptor, Melatonin, MT2